Transcenta Holding Limited announced the appointment of Daniel Weng as the company's CFO, reporting to Xueming Qian, CEO. As a member of the executive leadership team, Daniel will be fully responsible for the company's financial strategy, performance reporting, capital markets activities and investor relations, helping the company to take a leap forward. Prior to joining Transcenta, he served as the vice president and Head of finance at CStone Pharmaceuticals and has the overall responsibilities for financial functions, where he made tremendous contributions to commercial strategy leading to successful commercial launch in China and Taiwan as well as research and development prioritization. Prior to CStone Pharmaceuticals, he served as the vice president and head of finance at Everest Medicines. Before Amgen, Daniel spent nearly 15 years serving as the senior and executive finance professional at multinational companies like GE, Honeywell in China and overseas.